01_Alina 2


Study Proves PCSK9 Inhibitors Significantly Cuts the Incidence of Heart Attack and Death in Hard to Treat Patients

No Comments

St. Patrick’s Day will never be the same for me or for the over 1.3 million Americans who suffer from familial hypercholesterolemia (FH), a genetic condition causing soaring LDL cholesterol levels unrelated to diet or lifestyle. The reason is that today, March 17th, incontrovertible evidence was presented … Read More


New Collaboration Improves Access to Treatment for Familial Hypercholesteremia (FH) Patients Most at Risk for Early Heart Attacks and Death

No Comments

In collaboration with The FH Foundation, Express Scripts expands access to PCSK9 inhibitors for those with FH.

PASADENA, Calif., March 15, 2017 /PRNewswire-USNewswire/ — The FH Foundation, a patient-centered non-profit dedicated to research, advocacy, and education of all forms of familial … Read More


Clinical Trials

No Comments

Understanding Clinical Trials

Therapies are developed by researchers at academic and government research institutions, and pharmaceutical companies. First, they are tested in animals to understand safety risks (those are called Pre-Clinical Trials). The next step is to study the therapies in … Read More



One Second

1 Comment

One Second.

It’s true what they say. It only takes one second for your entire life to change. Everything is different. Uncertainty is the new normal. The day our six-year-old daughter was diagnosed with Homozygous Familial Hypercholesterolemia, a rare disease that can lead to heart disease, … Read More


Getting Personal

No Comments

I “I’m 31. How on earth did this happen?” My older brother Bryan sat up; his eyes were dazed after a restless night in the hospital. As Bryan lifted his arm to scratch his head, I could see the bruising on his wrist from the cardiac catheter. “I feel so much better,” he said. He showed me the … Read More




1 2 3 28